David J. Wright

584 total citations
8 papers, 438 citations indexed

About

David J. Wright is a scholar working on Molecular Biology, Infectious Diseases and Cellular and Molecular Neuroscience. According to data from OpenAlex, David J. Wright has authored 8 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in David J. Wright's work include Protein Degradation and Inhibitors (3 papers), HIV/AIDS drug development and treatment (2 papers) and Ion Channels and Receptors (2 papers). David J. Wright is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), HIV/AIDS drug development and treatment (2 papers) and Ion Channels and Receptors (2 papers). David J. Wright collaborates with scholars based in United Kingdom and Japan. David J. Wright's co-authors include Tom D. Heightman, Honorine Lebraud, Christopher N. Johnson, David J. Beech, Robin S. Bon, Katie J. Simmons, Stephen P. Muench, Hussein N. Rubaiy, Katsuhiko Muraki and Aisling Minard and has published in prestigious journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, European Journal of Pharmaceutics and Biopharmaceutics and Cells.

In The Last Decade

David J. Wright

8 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Wright United Kingdom	6	357	145	85	63	62	8	438
Marscha Hirschi United States	8	354 1.0×	61 0.4×	10 0.1×	22 0.3×	119 1.9×	10	547
Olof Gissberg Sweden	9	317 0.9×	58 0.4×	7 0.1×	25 0.4×	7 0.1×	15	458
Min Wong United States	7	195 0.5×	25 0.2×	7 0.1×	27 0.4×	50 0.8×	10	269
Crystal R. Archer United States	9	284 0.8×	67 0.5×	17 0.2×	36 0.6×	13 0.2×	14	395
Maria Reinecke Germany	6	318 0.9×	43 0.3×	8 0.1×	22 0.3×	4 0.1×	11	455
Snahel Patel United States	9	187 0.5×	46 0.3×	5 0.1×	86 1.4×	7 0.1×	10	325
Eva J. van Rooden Netherlands	11	233 0.7×	89 0.6×	9 0.1×	135 2.1×	2 0.0×	15	394
Edward Pichinuk Israel	12	245 0.7×	52 0.4×	7 0.1×	55 0.9×	2 0.0×	22	422
Dušan Ružić Serbia	11	235 0.7×	56 0.4×	11 0.1×	114 1.8×	2 0.0×	24	366

Countries citing papers authored by David J. Wright

Since Specialization

Citations

This map shows the geographic impact of David J. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Wright more than expected).

Fields of papers citing papers by David J. Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Wright. The network helps show where David J. Wright may publish in the future.

Co-authorship network of co-authors of David J. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Wright. A scholar is included among the top collaborators of David J. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Wright. David J. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Wright, David J., et al.. (2025). 2-Hydroxypropyl-β-cyclodextrin, solubiliser in a novel dantrolene formulation: Its binding affinities to clinical compounds that may be used during anaesthesia or management of malignant hyperthermia. European Journal of Pharmaceutics and Biopharmaceutics. 214. 114765–114765. 1 indexed citations

Wright, David J., et al.. (2020). Human TRPC5 structures reveal interaction of a xanthine-based TRPC1/4/5 inhibitor with a conserved lipid binding site. Communications Biology. 3(1). 704–704. 44 indexed citations

Minard, Aisling, Claudia Bauer, David J. Wright, et al.. (2018). Remarkable Progress with Small-Molecule Modulation of TRPC1/4/5 Channels: Implications for Understanding the Channels in Health and Disease. Cells. 7(6). 52–52. 41 indexed citations

Wright, David J., Marc O’Reilly, & Dominic Tisi. (2017). Engineering and purification of a thermostable, high-yield, variant of PfCRT, the Plasmodium falciparum chloroquine resistance transporter. Protein Expression and Purification. 141. 7–18. 5 indexed citations

Lebraud, Honorine, et al.. (2016). In-gel activity-based protein profiling of a clickable covalent ERK1/2 inhibitor. Molecular BioSystems. 12(9). 2867–2874. 18 indexed citations

Lebraud, Honorine, David J. Wright, Christopher N. Johnson, & Tom D. Heightman. (2016). Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras. ACS Central Science. 2(12). 927–934. 310 indexed citations

Wright, David J. & Christopher G. Tate. (2015). Isolation and characterisation of transport-defective substrate-binding mutants of the tetracycline antiporter TetA(B). Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(10). 2261–2270. 7 indexed citations

Riedinger, Christiane, M.E.M. Noble, David J. Wright, et al.. (2011). Understanding Small‐Molecule Binding to MDM2: Insights into Structural Effects of Isoindolinone Inhibitors from NMR Spectroscopy. Chemical Biology & Drug Design. 77(5). 301–308. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact